Healthcare Fraud Detection Market Share, Leading Players and Demand Forecast Report 2032

 

Market Analysis

The global healthcare fraud detection market share is projected to reach at CAGR 29.5% during the forecast year 2023-2032. Healthcare fraud takes places when a healthcare provider or an insured person offers misleading or false information to health insurance companies with an intention to have it paid to another party, individual, healthcare provider or policy holder for unauthorized benefits. Health care fraud comprise of medical fraud, drug fraud and health insurance fraud. Some common examples of such fraud include misrepresenting dates, duration, description of services and frequency, submitting claims for services that is not provided, numerous claims filed for same patients by different providers, data falsification by physicians. Healthcare fraud detection will help to prevent healthcare fraud, abuse and waste.

There are many factors that is driving the growth of the healthcare fraud detection market. Some of these factors as per the Market Research Future (MRFR) report include increasing fraudulent activities in the healthcare sector, growing number of patients looking for health insurance, prepayment review model, increasing pressure of abuse, waste and fraud on healthcare spending, high investment returns, and thorough and stringent checks in claims procedure to reduce losses to insurance companies. On the contrary, factors such as requirement for recurrent upgrades made in the fraud detection software, time-consuming deployment and the reluctance to use healthcare fraud analytics especially in the developing economies may impede the healthcare fraud detection market growth.

Key Players

healthcare fraud detection market players include Pondera Solutions, Northrop Grumman, DXC Technology, CGI Group, Scio Health Analytics, International Business Machines Corporation (IBM), LexisNexis, Wipro, Conduent, HCL Technologies, SAS Institute, Fair Isaac, McKesson, Verscend Technologies, Optum and others.  

Market Segmentation

Market Research Future report offers an all-inclusive segmental analysis of the healthcare fraud detection market on the basis of component, end-user, delivery model, application and type.

Based on component, it is segmented into software and services. Of these, services will dominate the market over the estimated years.

Based on end-users, the healthcare fraud detection market outlook is segmented into private insurance payers, employers, government agencies and others.

Based on delivery model, it is segmented into on-premise and on-demand delivery models. Of these, on-demand will dominate the market.

Based on application, the healthcare fraud detection market is segmented into insurance claims review and payment integrity. The insurance claims review is again segmented into post and prepayment review. Of these, insurance claims review will dominate the market.

Based on type, it is segmented into prescriptive analytics, descriptive analytics and predictive analytics. Of these, descriptive analytics will lead the healthcare fraud detection market over the estimated years.

Regional Analysis

Based on region, the healthcare fraud detection market insights covers growth opportunities and latest trends across Americas, Europe, Asia Pacific and Middle East and Africa. Of these, Americas will govern the market over the estimated years owing to increasing fraud cases in healthcare sector, promising government initiatives for preventing fraud in healthcare sector and more and more people requesting for health insurance. This will be followed by Europe that holds the second position owing to rising incidences of corruption and healthcare fraud in the region, developing state to cut down fraud within the healthcare sector and progress of the information technology sector. In the APAC region, the healthcare fraud detection market is predicted in being the fastest developing due to increasing frequency of frauds, evolving IT sector and constantly developing economies. On the other hand, the healthcare fraud detection market in the Middle East and Africa will have the least share. The Middle Eastern region however is anticipated to have a key share owing to the increasing health insurance frauds cases.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Irritable Bowel Syndrome Treatment Market Share, Size, Trends, Industry Analysis Report to 2032

 

Overview:

 

The Global Irritable Bowel Syndrome Treatment Market Share is showing impressive signs of attaining a CAGR of 8.1% between 2023 and 2032. Irritable bowel syndrome is a disease that triggers immense pain in the stomach that, if not cured in time, could lead to depression. The problem can be a long-lasting one. Market Research Future (MRFR) report has found out that the market is evolving due to the growing awareness that is making people seek better treatment.

 

Several factors like better market awareness, high expenditure capacity, and increasing ingress of various technologies can impact the global market. Pharmaceutical industries are impacting the market with various innovation and others.

 

Competitive Landscape:

 

Global Irritable Bowel Syndrome Treatment Market Players are Allergan Inc., Valeant Pharmaceuticals international, Inc., Lexicon Pharmaceuticals, Inc., Astellas Pharma, Inc., Mallinckrodt, Synergy Pharmaceuticals Inc., Nestle Health Science, Ardelyx, Inc., Ironwood Pharmaceuticals, and Abbott. MRFR recorded the latest moves initiated by these companies to make sure that a chart can be drawn for the market in the future, which can be used to predict various movements in the coming days.

 

 

Segmentation:

 

The report on the global irritable bowel syndrome treatment market outlook makes it extensive by segmenting the market into type, drug type, and end user. These segments carry various factorial details and trigger better understanding with volume-wise and value-wise understanding.

 

By type, the global market for irritable bowel syndrome treatment includes IBS-C, IBS-D, and IBS-M. IBS-D is has the potential to emerge as the major shareholder over the forecast period.

 

By drug type, the report on the global irritable bowel syndrome treatment market insights includes linaclotide, lubiprostone, rifaximin, eluxadoline, and alosetron. The Linaclotide segment has the potential to take over the market.

 

By end use, the report containing study of the global irritable bowel syndrome treatment market encompasses clinics, research laboratories, hospitals, and others. The Hospitals segment has the better market coverage.

 

Regional Analysis:

 

North America is expected to make better contribution for the irritable bowel syndrome market. The regional market has better market opportunities due to their high expenditure capacity. Better healthcare facilities, high investment for research & development sector, medicines lined up in the pipeline, and others are expected to make strong contributions for the regional market. In addition, the presence of top-notch pharmacies and countries like the US, Canada, and others are expected to earn more revenues for the market.

 

Europe is expected to portray similar growth patterns, which can trigger a high influx of revenues. The market is also known for the presence of several market players who are impacting it with their innovations. On the other hand, they are collaborating with various other players to make substantial impact on the market.

 

The APAC market has better opportunities as the global players are looking for constant incorporation of efforts from regional governments, which they are receiving. In addition, the region has become a perfect business expansion plans for these companies. Hike in expenditure capacity, better medical facilities, and others are expected to make the market contribute the most in the coming years. Its massive population can also play a crucial role by allowing easy permeation for the market.

 

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

 

 

Small Molecule API Market Share Expected to reach a notable valuation by 2032

 

Market Insights:

Market Research Future (MRFR)’s latest study asserts that the global small molecule API market is set to expand at a CAGR of 7.0% during the forecast period 2023 to 2030. The global small molecule API market share is set to reach a healthy growth by 2030. The increased investments in the research & findings coupled with government support are likely to propel the market growth in the forthcoming years.

The pharmaceutical industry is presently making massive profits and is equipped with developed infrastructure. The pharmaceutical industry is anticipated to expand in the foreseeable future. This, in turn, is expected to drive the growth of the small molecule API market. Additionally, the increase in the prevalence of diseases coupled with the discovery of new viruses and diseases is prognosticated to affect the small molecule API market proliferation positively.

Some of the factors responsible for favoring the expansion of the small molecule API market include growing demand for small molecule drugs, rising access to the medication in developing and underdeveloped countries, entry of big CMOs into the market, etc. Furthermore, rising burden of cardiovascular diseases and cancer is forecasted to intensify the competition among the players of the small molecule API market. According to the American Cancer Society, 1,735,350 new cancer cases and 609,640 cancer deaths are estimated in the U.S. alone.

Competitive Dashboard:

Small Molecule API Market players profiled in the report are Albemarle Corporation, Dr. Reddy’s Laboratories Ltd, GlaxoSmithKline Plc, Lonza, Merck Sharp & Dohme Corp., Allergan Plc, Aurobindo Pharma, Cambrex Corporation, Mylan N.V., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd, Novartis AG, Pfizer Inc., and Siegfried AG.

Market Segmentation:

By type, the small molecule API market outlook has been segmented into synthetic/chemical API, and biological API. Synthetic/chemical API segment currently holds 81.4% share of the market. It is likely to retain its pole position over the forecast period.

By application, the global small molecule API market is segmented into cardiovascular, oncology, diabetes, immunological disorders, and others. The cardiovascular segment held the maximum share of the market in 2015. It is anticipated to show positive growth across the review period.

By manufacturing method, the small molecule API market has been segmented into in-house and contract.

Regional Analysis:

By region, the global small molecule API market insights has been segmented into North America, Europe, Asia Pacific, and the Middle East & Africa. North America is the largest market for small molecule API. It is expected to retain a significant market share through the assessment period. The factors favoring the expansion of the regional market include developed healthcare sector, availability of funds, increasing clinical trials, rising burden of cancer, etc.

Europe is the second largest small molecule API market. It is estimated to exhibit healthy growth over the next few years. The growth is attributable to the initiatives undertaken by the governments to support the expansion oh pharmaceutical industry. Furthermore, the availability of funds coupled with the adoption of next-gen healthcare technology is anticipated to aid market proliferation in the region.

Asia Pacific is projected to thrive at the highest CAGR during the review period. The Asian countries have an abundance of raw materials required for drug manufacturing. Additionally, low labor cost and regulatory relaxations have aided profit maximization for the regional market players. Asia Pacific is one of the significant exporters of small molecule drug, and the trend is projected to continue over the next few years.

The Middle East & Africa is set to exhibit steady growth. The African regions lack proper healthcare facilities and resonate strong growth opportunities. However, the Middle Eastern countries such as Qatar and Kuwait are expected to witness considerable growth due to the developed healthcare sector and increasing awareness.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Smart Inhalers Market Share accelerating a CAGR during the forecast period

 

Smart Inhalers Market – Overview

The use of smart technology has established a smart presence in the healthcare domain. This has led to an increased number of smart devices. Market focused reports linked with the healthcare industry among others recently have been made available by Market Research Future which issues reports on this industry. The smart inhalers market share is projected to expand with a 23.50% CAGR approximately while earning revenues worth USD 2.00 billion by the end of the forecast period 2032.

The need to monitor medicine dosage and schedule the medicine intake in the market for smart inhalers has grown considerably. Due to the prevalence of ailments like asthma, the market has grown considerably over the past few years. As asthma patients are required to monitor their drug intake diligently, the smart inhalers provide a great degree of convenience in that regard. The development of the market is also powered by the incorporation of cutting-edge technologies in these products.

Global Competitive Analysis

The impetus for the market’s growth has altered the competitive background of the market. By ensuring supply and demand are in balance the competitors can unlock new opportunities for growth. The key players and trends have created a positive tone for development. The important trends and players have established a positive tone for development. The opportunities for growth and innovation have increased at a rapid pace transforming the landscape of the market. Engaging and converting prospective opportunities is modifying the growth pace of the market considerably. The competitors in the market have been spurred to devise strategic road-maps that capitalize on the positive market cues.

Smart inhalers market players are AstraZeneca, Gecko Health Innovations Inc., Cohero Health, Adherium, GlaxoSmithKline, Inspiro Medical, and Propeller Health.        

Industry Segments 

The smart inhalers market outlook has been segmented on the basis of application, type, end user, and region. On the basis of type, the segment involves metered dose inhaler and dry powder inhaler. The dry powder inhalers control the principal share of the market. The application basis of segmentation of the market consists of asthma, COPD, and others. The end user segmentation of the market is segmented into respiratory care center, hospitals & clinics, and others. On the basis of regions, the market includes North America, APAC, Europe and rest of the world.

Detailed Regional Analysis

The smart inhalers market insights comprises regions such as North America, Middle East, Europe, Africa, APAC and rest of the world.  Globally, the North American region is the major market for smart inhalers which is predicted to touch $888.4 million in revenues approximately by 2023. The European region was the second biggest market in 2016 which is worth $57.4 million. Additionally, the Asia Pacific market is anticipated to be the most rapidly growing market and is likely to develop at a CAGR of 55.3 percent during the forecast period from 2016 to 2022. The smart inhalers market in the rest of world is anticipated to surge after 2019.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

 

Enteral Feeding Devices Market Outlook, Trends, Size and Forecast To 2032

 

Market Overview

The global Enteral Feeding Devices Market share is predicted to meet the market value of USD 6.01 Billion by 2032 at a 5.10% CAGR for the forecast period of 2023 to 2032, according to the latest research report from Market Research Future (MRFR). The global enteral feeding devices market is profiled in detail in the report, which provides a comprehensive overview of the market’s leading drivers and restraints as well as the leading players operating in the market.

Enteral feeding devices are used to feed people who, permanently or temporarily, have lost the ability to feed themselves due to the disease or disorder. Enteral feeding devices are used to directly deliver nutrients into some part of the small intestine or stomach, so that at-risk patients can be fed under complete supervision. Enteral feeding devices also allow doctors to monitor and manage the temporary nutrition of specific individuals in order to make sure they are being fed as much and what they should be fed, considering specific diseases and disorders. The growing geriatric population around the world is likely to be a major driver for the global enteral feeding devices market over the forecast period, as the geriatric population is likely to be a major consumer of technologies that allow them to be fed without the hassle of physically feeding themselves. The growing number of geriatric individuals suffering from neurodegenerative diseases is also likely to be a major driver for the global Enteral Feeding Devices Market.

Competitive Analysis:

Leading Enteral Feeding Devices Market Players include:  

§  Medtronic plc,

§  Cook Medical,

§  B. Braun Melsungen AG,

§  Abbott Laboratories,

§  Boston Scientific Corporation,

§  Becton,

§  Dickinson and Company (BD),

§  Fresenius Kabi AG,

§  Danone Nutricia,

§  Nestlé,

§  CONMED Corporation,

§  Moog, Inc.,

§  Halyard Health, Inc., and

§  Vygon SA.

Segmentation:

The global enteral feeding devices market outlook has been segmented on the basis of product, age group, indication, end user, and region. 

·       By product, the market has been segmented into enteral feeding tubes, enteral feeding pumps, enteral syringes, administration sets, and consumables. The enteral feeding tubes segment is further categorized into enterostomy feeding tubes, nasoenteric feeding tubes, and oroenteric feeding tubes. The enterostomy feeding tubes segment is additionally divided into gastrostomy tubes, jejunostomy tubes, and gastrojejunostomy tubes. The nasoenteric feeding tubes segment is further classified into nasogastric feeding tubes, nasojejunal feeding tubes, and nasoduodenal feeding tubes. The enteral feeding pumps segment is expected to dominate the market throughout the forecast period due to low risk of complications with the use of feeding pumps, enhanced portable pump designs, and the increasing adoption of pumps in hospitals and home care settings.

·       On the basis of age group, the market has been divided into adults and pediatrics. 

·       By indication, the market has been classified into cancer, gastrointestinal diseases, diabetes, neurological disorders, hypermetabolism, and others. The cancer segment is further categorized into gastrointestinal cancer, head & neck cancer, liver cancer, pancreatic cancer, esophageal cancer, and others. 

·       Based on end user, the market has been categorized into hospitals, home care settings, and ambulatory surgery centers (ASCs). 

Major players in the global enteral feeding devices market  are likely to focus on developing products that fit regulatory standards and enable steady growth for the company in the market. The growing scope for the medical devices sector in Asia Pacific is likely to be a key factor for the global enteral feeding devices market over the forecast period. 

Regional Analysis:

The Americas dominates the global enteral feeding devices market, followed by Europe. Asia Pacific is also likely to grow at a high CAGR over the forecast period. 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013               

 

Microelectronic Medical Implants Market Trends & Overview by 2032

 Market Scenario:

The global Microelectronic Medical Implants Market Size is expected to grow at a CAGR of 11.5% over the forecast period of 2022-2030, reveals a research report published by Market Research Future (MRFR). The market has observed rapid growth on account of rising prevalence of cardiac disorders such as cardiac arrest, heart failure, artery diseases, stroke. Such cardiac diseases accelerate the demand for medical implants such as Pacemakers, Defibrillators, and Neurostimulators which positively impact the market growth. Growth in incidences of other chronic diseases such as epilepsy and Parkinson's disease also add to market growth. The rise in the geriatric population who are more likely to acquire such diseases also propel the growth of the market.

Competitive Landscape

The global microelectronic medical implants market players are highly competitive and is characterized by the presence of many established players. The key players functioning in the market include

Abiomed Inc,

Cyberonics Inc.,

Medtronic Inc.,

Neuropace Inc.,

St. Jude Medical Inc.,

Biomet Inc.,

Envoy Medical,

Microsemi Corporation.,

Retina Implant AG,

Worldheart Corporation and

others.

The key players are implementing various strategies such as partnership, mergers, acquisition, product launches to sustain their position in the market.

Segmentation

The global microelectronic medical implants market has been segmented based on product and application.

By product, the market has been segmented into neurostimulators, drug infusion pumps, and others.

By application, the market has been segmented into pacemakers, defibrillators, neurostimulators, spinal fusion stimulators, implantable drug pumps, hearing implants, eye implants, ocular implants and others.

Regional Analysis

The key markets of the global microelectronic medical implants market include North America, Europe, Asia Pacific and the Middle East & Africa. North America accounts for the largest share of the market owing to favorable government policies and growing incidences of cardiac diseases in the region and is expected to grow at a CAGR of 8.7% over the forecast period. Europe follows North America closely and is expected to grow at a CAGR of 8.9% over the forecast period. Asia Pacific is slated to emerge as the fastest growing market owing to the growing healthcare sector and increased medical expenditure in the region. Moreover, the region has a large patient pool which provides growth opportunities in the future.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Dental Chair Market By Business Top Key Players, Growth & Trend to 2032

 Market Overview:

The Dental Chair Market Size is expected to reach USD 1.12 Billion by 2032 at 5.5% CAGR during the forecast period 2023-2032. The two most significant aspects to consider when designing a dental chair are the patient's convenience during dental operations and the dentist's ease while conducting dental treatment, particularly dental surgery. Presently, there are two types of dental chairs: one that is powered by electricity and another that is powered by a manual or non-powered source.

The global Dental Chair Market Share is witnessing a continual rise. Market growth attributes to growing dental issues and dental practices across the globe. Besides, improvements in the functionality of dental chairs drive the growth of the market. Dental chairs play a causal role in improving the patient experience during dental treatments. Increased patient comfort during performing dental procedures and dental surgeries act as a significant growth driver.

Global Dental Chair Market – Competitive Analysis

The dental chair market appears highly competitive and fragmented due to many well-established players forming a competitive landscape. These players adopt strategic approaches such as mergers & acquisitions, collaboration, expansion, and technology launch to strengthen their market positions. 

They invest substantially in developing new technologies and upgrade their existing manufacturing techniques. Also, they make substantial investments to expand their global footprints. They continuously seek improvement and innovation and try to provide quality dental chairs and superior service to their clients, creating service-driven and trusted relationships traders and suppliers.

Major Players:

The Dental Chair Market Players are included.

Dentsply Sirona,

Patterson Dental Supply, Inc.,

PLANMECA OY,

Henry Schein, Inc.,

A-dec Inc.,

Danaher Corporation,

Craftmaster Contour Equipment, Inc.,

Midmark,

KaVo Dental GmbH, and

XO CARE A/S, among others. 

Global Dental Chair Market – Segmentation

The report is Dental Chair Market Segment into four dynamics;

·        By Product: Powered Dental Chairs and Non-Powered Dental Chairs.

·        By Type : Fixed Dental Chair and Portable Dental Chair.

·        By Application: Examination, Oral Surgery, Orthodontics, and others.

·        By Regions:  North America, Europe, APAC, and Rest of the World.

Moreover, surging demand for dental aesthetic treatments and dental procedures escalate market growth. According to Market Research Future (MRFR), the global dental chair market outlook is expected to reach a valuation of USD 627.1 MN by 2030, registering 4.1% CAGR over the assessment period (2022 – 2030). The spurting rise in the number of dental examinations and procedures performed worldwide, create huge market demand.

Dental Chair Market – Regional Analysis

North America leads the global dental chair market, heading with the increasing numbers of dentists and dental treatment procedures in the region. Also, factors such as the strong presence of major industry players and well-equipped dental care centers drive regional market growth. Besides, increasing R&D activities carried with substantial investments for the development of innovative products boosts the growth of the regional market.

Additionally, the increasing demand for prosthodontics and raising awareness about oral health push the growth of the regional market. Furthermore, the high expenditures on oral care, increasing demand for better dental care infrastructures, and rapid uptake of new technologies in the manufacturing substantiate the regional market growth. The dental chair market in North America is projected to retain its dominance over the global market throughout the review period.

Europe holds the second-leading position in the global dental chair market due to the well-established dentistry in the region. Moreover, factors such as the strong presence of key dental chair manufacturers and the increasing number of dental practices propel the regional market growth. Rise in numbers of dentists creates a high demand for dental equipment, including the dental chair. Besides, rising cases of root canal procedures and oral & dental surgeries boost the growth of the regional market. The dental chair market in Europe is expected to create a substantial revenue pocket.

The Asia Pacific dental chair market is growing rapidly. Factors such as the augmenting demand for dental procedures and rising numbers of dental care providers in the region foster market growth. Moreover, increasing per capita healthcare expenses and developing healthcare infrastructure drive the regional market growth excellently. Besides, the proliferation of oral health insurance propels the growth of the regional market. Additionally, the rapidly growing population, healthcare sectors, and the growing focus on improving the healthcare facilities contribute to the regional market growth.

Related reports-

Robot-Assisted Surgical Systems Market

3D Printing Medical Devices Market

Pacemaker Market

 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013